Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Forecasted Market Size Estimates For The Biological Safety Testing Products And Services Market Between 2025 And 2029?
The market for biological safety testing products and services has experienced significant expansion recently. This market is projected to expand from $5.4 billion in 2024 to $6.12 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 13.3%. Historically, this expansion has been driven by factors such as the increased occurrence of relevant diseases, the growing manufacturing of next-generation biologics, an escalating demand for biologics, a greater embrace of testing instruments, the development of the pharmaceutical and biotechnology sectors, and a heightened focus on adherence to regulations.
The biological safety testing products and services market is projected to experience rapid growth over the next few years. It is anticipated to expand to “$10.04 billion” by “2029”, exhibiting a compound annual growth rate (CAGR) of “13.2%”. This growth during the forecast period can be attributed to the increasing importance of assessing their safety and effectiveness in treating health problems, the expanding development of new therapeutics and treatments, a rising interest in developing cell and gene therapies, escalating investments in the biopharmaceutical sector, and growing government initiatives to promote biopharmaceutical safety. Major trends expected in this period include technological advancements, an increasing demand for bioburden testing, heightened investments in biopharmaceuticals and biologics, regulatory compliance driving market adoption, and mergers and acquisitions among key industry players.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18258&type=smp
Which Drivers Are Supporting Growth Of The Biological Safety Testing Products And Services Market?
The increasing need for gene therapies is anticipated to drive the expansion of the biological safety testing products and services market in the future. Gene therapy represents a medical strategy employing genes to address or avert illnesses through the replacement, alteration, or addition of defective genes. Enhanced investment and research focusing on gene mutation, combined with favorable regulatory frameworks, are accelerating innovation and broadening the applications of gene therapeutics. In the context of gene therapy, biological safety testing products and services are crucial for guaranteeing that viral vectors and genetic materials are free from contaminants and safe for application. For example, a document released by the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, in January 2024, indicated that in quarter four, 2023, there was a 10% rise in the number of gene therapies in Phase III clinical trials. This marked the first such quarterly increase observed since quarter three, 2022. Consequently, the escalating demand for gene therapies is a key driver for the biological safety testing products and services market.
How Is The Biological Safety Testing Products And Services Market Classified Into Different Segments?
The biological safety testing products and servicesmarket covered in this report is segmented –
1) By Product: Reagents And Kits; Instruments; Services
2) By Test Type: Endotoxin Tests; Sterility Tests; Cell Line Authentication And Characterization Tests; Bioburden Tests; Adventitious Agent Detection Tests; Residual Host Contamination Detection Tests; Other Test Types
3) By Application: Vaccines And Therapeutics; Blood And Blood-Based Products; Gene Therapy; Tissue And Tissue-based Products; Stem Cell
Subsegments:
1)By Reagents And Kits: Endotoxin Testing Kits; Mycoplasma Detection Kits; Sterility Testing Kits; Microbial Detection Reagents; Cell Culture Media Reagents
2) By Instruments: PCR Instruments; Microplate Readers; Bioluminescence Detection Systems; Automated Cell Culture Systems; ELISA Readers
3) By Services: Microbial Testing Services; Biocompatibility Testing Services; Endotoxin Testing Services; Environmental Monitoring Services; Consulting And Validation Services
Which Key Trends Are Expected To Influence The Biological Safety Testing Products And Services Market In The Coming Years?
Leading companies in the biological safety testing products and services market are creating swift, animal-free bacterial endotoxin tests with the goal of improving patient safety and speeding up drug development. This innovative methodology aims to decrease testing periods and enhance reliability without incorporating animal-based products. For example, in January 2024, Charles River Laboratories International, a US-based pharmaceutical and biotechnology company, launched the Endosafe Trillium cartridge. This device uses recombinant technology to identify and quantify endotoxins, completely avoiding animal-derived materials. It stands as the first rapid animal-free bacterial endotoxin test offering a quicker turnaround time and removing the requirement for animal-derived reagents, thereby promoting greater sustainability and ethical testing approaches. The objective of this product is to deliver fast, accurate results while lessening dependence on the traditional Limulus amebocyte lysate (LAL) extracted from horseshoe crabs.
Who Are The Core Companies Influencing The Biological Safety Testing Products And Services Market Landscape?
Major companies operating in the biological safety testing products and services market are Merck KGaA, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, SGS Société Générale de Surveillance SA, Eurofins Scientific, Agilent Technologies Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories Inc., BioMérieux SA, Almac Group, Samsung Biologics Co. Ltd., Maravai LifeSciences Holdings Inc., Genscript Biotech Corp, Wako Pure Chemical Industries Ltd., Associates of Cape Cod Inc., InvivoGen S.A.S., Microcoat Biotechnologie GmbH, BSL BIOSERVICE Scientific Laboratories Munich GmbH, Redberry, PathoQuest
Download The Full Report For Exclusive Market Findings:
How Does The Biological Safety Testing Products And Services Market Perform Across Key Geographic Regions?
North America was the largest region in the biological safety testing products and services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological safety testing products and services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Biological Safety Testing Products And Services Market Report:
https://www.thebusinessresearchcompany.com/customise?id=18258&type=smp
Browse Through More Reports Similar to the Global Biological Safety Testing Products And Services Market 2025, By The Business Research Company
Biological Wastewater Treatment Global Market Report 2025
Cbrn Chemical Biological Radiological And Nuclear Security Global Market Report 2025
Biological Seed Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biological-seed-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model